Oscar Health, Inc. (NYSE:OSCR) Stock Now Rated “Hold” by Wall Street Brokerages

Oscar Health, Inc. (NYSE:OSCR) has earned an average rating of “Hold” from the thirteen brokerages that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $33.90.

OSCR has been the subject of a number of research reports. UBS Group upped their target price on shares of Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Wells Fargo & Company increased their price objective on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Thursday, August 13th. Finally, Raymond James Financial raised their price objective on Oscar Health from $34.00 to $42.00 and gave the company an “outperform” rating in a research report on Friday, September 18th.

Insider Buying and Selling

In related news, Director Mario Schlosser sold 31,422 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $988,221.90. Following the completion of the transaction, the director directly owned 449,444 shares of the company’s stock, valued at approximately $14,135,013.80. This represents a 6.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 28,869 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $907,930.05. Following the transaction, the chief financial officer owned 1,046,108 shares of the company’s stock, valued at $32,900,096.60. This represents a 2.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 874,451 shares of company stock valued at $26,761,671 in the last ninety days. Company insiders own 22.64% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. BIT Capital GmbH lifted its holdings in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after acquiring an additional 5,227,152 shares during the last quarter. Bank of America Corp DE grew its holdings in Oscar Health by 205.1% during the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock valued at $32,808,000 after purchasing an additional 1,922,732 shares during the last quarter. Wedge Capital Management L L P NC bought a new position in Oscar Health during the 2nd quarter valued at about $32,855,000. Dimensional Fund Advisors LP raised its position in Oscar Health by 22.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock worth $48,078,000 after purchasing an additional 759,837 shares during the period. Finally, BNP Paribas Financial Markets raised its position in Oscar Health by 1,016.9% in the 4th quarter. BNP Paribas Financial Markets now owns 728,920 shares of the company’s stock worth $10,475,000 after purchasing an additional 663,659 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Stock Up 3.5%

Shares of OSCR opened at $30.95 on Tuesday. The business’s 50 day moving average is $30.83 and its 200 day moving average is $25.17. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health has a 12-month low of $10.69 and a 12-month high of $34.48. The company has a market capitalization of $9.55 billion, a PE ratio of 22.11, a price-to-earnings-growth ratio of 0.34 and a beta of 2.47.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm’s revenue for the quarter was up 70.4% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.89) EPS. Research analysts expect that Oscar Health will post 1.83 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc is a technology-driven health insurance company that provides health plans and related services to individuals, families and businesses in the United States. The company primarily serves members through plans offered under the Affordable Care Act (ACA), including individual and family coverage purchased through government marketplaces.

Oscar’s offerings include medical insurance plans with access to provider networks, prescription drug coverage and member support services.